Artemis Medicare

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE025R01021
  • NSEID: ARTEMISMED
  • BSEID: 542919
INR
269.50
2.15 (0.8%)
BSENSE

Dec 05

BSE+NSE Vol: 1.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
936.92
878.57
737.43
554.80
408.40
565.02
546.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
936.92
878.57
737.43
554.80
408.40
565.02
546.52
Raw Material Cost
0.00
0.00
0.00
0.00
114.89
141.24
129.41
Purchase of Finished goods
0.00
0.00
0.00
0.10
0.30
1.49
1.45
(Increase) / Decrease In Stocks
0.01
0.00
0.00
0.13
1.27
-3.84
-0.28
Employee Cost
148.37
138.95
120.78
104.30
83.99
103.42
97.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
565.21
540.31
459.93
341.54
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
71.54
66.61
62.77
41.28
172.76
261.25
254.85
Total Expenditure (Excl Depreciation)
785.13
745.87
643.48
487.35
373.21
503.56
482.71
Operating Profit (PBDIT) excl Other Income
151.79
132.70
93.95
67.45
35.19
61.46
63.81
Other Income
32.99
7.35
7.34
3.90
3.54
4.60
4.00
Operating Profit (PBDIT)
184.78
140.05
101.29
71.35
38.73
66.06
67.81
Interest
31.94
31.29
19.68
11.98
12.93
12.80
11.00
Exceptional Items
0.00
0.00
0.00
0.00
3.23
0.00
0.00
Gross Profit (PBDT)
152.84
108.76
81.61
59.37
29.03
53.26
56.81
Depreciation
45.16
40.32
31.00
22.19
21.51
22.63
20.07
Profit Before Tax
107.67
68.45
50.61
37.18
7.53
30.63
36.74
Tax
25.49
19.31
12.59
5.78
1.37
11.17
16.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
82.18
49.14
38.01
31.40
6.16
19.46
20.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
82.18
49.14
38.01
31.40
6.16
19.46
20.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.45
0.00
0.59
0.41
0.33
0.33
0.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
82.63
49.14
38.60
31.81
6.49
19.79
20.49
Equity Capital
13.76
13.59
13.41
13.24
13.24
13.24
13.24
Face Value
1.0
1.0
1.0
1.0
10.0
10.0
10.0
Reserves
755.43
366.78
0.00
279.26
240.57
234.02
214.55
Earnings per share (EPS)
6.01
3.62
2.88
2.4
4.9
14.95
15.48
Diluted Earnings per share
5.31
3.53
2.79
2.29
4.9
14.95
15.48
Operating Profit Margin (Excl OI)
16.2%
15.1%
12.74%
12.16%
8.62%
10.88%
11.68%
Gross Profit Margin
16.31%
12.38%
11.07%
10.7%
7.11%
9.43%
10.39%
PAT Margin
8.77%
5.59%
5.15%
5.66%
1.51%
3.44%
3.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.64% vs 19.14% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 68.15% vs 27.31% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 14.39% vs 41.25% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 2.08% vs 58.99% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Artemis Medicare With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
936.92
0
936.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
936.92
0
936.92
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.01
0
0.01
Employee Cost
148.37
0
148.37
Power Cost
0.00
0
0.00
Manufacturing Expenses
565.21
0
565.21
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
71.54
0.00
71.54
Total Expenditure (Excl Depreciation)
785.13
0
785.13
Operating Profit (PBDIT) excl Other Income
151.79
0.00
151.79
Other Income
32.99
0
32.99
Operating Profit (PBDIT)
184.78
0
184.78
Interest
31.94
0
31.94
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
152.84
0
152.84
Depreciation
45.16
0
45.16
Profit Before Tax
107.67
0
107.67
Tax
25.49
0
25.49
Provisions and contingencies
0.00
0
0.00
Profit After Tax
82.18
0
82.18
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
82.18
0
82.18
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.45
0
0.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
82.63
0
82.63
Equity Capital
13.76
0
13.76
Face Value
1.00
0
0.00
Reserves
755.43
0
755.43
Earnings per share (EPS)
6.01
0
6.01
Diluted Earnings per share
5.31
0
5.31
Operating Profit Margin (Excl OI)
16.20%
0%
0.00
16.20%
Gross Profit Margin
16.31%
0%
0.00
16.31%
PAT Margin
8.77%
0%
0.00
8.77%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 936.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.64% vs 19.14% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 82.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 68.15% vs 27.31% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.39% vs 41.25% in Mar 2024

Annual - Interest
Interest 31.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.08% vs 58.99% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.20%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024